Eli Lilly investeert 40 miljoen dollar in AI-bedrijf voor kaalheidsbehandeling

Pharmaceutical company Eli Lilly has invested $40 million in Absci, an AI-driven biotech firm developing injectable treatments for hair loss. The investment reflects growing confidence in injectable therapeutics, following the mainstream adoption of weight-loss drugs like Zepbound and Mounjaro.